tetrandrine has been researched along with Bone Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Chen, Y; Dong, C; Huang, Y; Luo, X; Tan, T; Wang, N; Yang, S | 1 |
| Chen, HQ; Deng, ZL; He, BC; Liu, Y; Luo, SH; Tian, DD; Wang, Y; Wu, N; Yuan, W; Zhang, RX | 1 |
| Barnett, D; Fanelli, M; Gudeman, B; Hattinger, CM; Michelacci, F; Picci, P; Serra, M; Tavanti, E; Vella, S | 1 |
| Li, F; Lu, Y; Sun, J; Xu, T | 1 |
4 other study(ies) available for tetrandrine and Bone Neoplasms
| Article | Year |
|---|---|
Tetrandrine suppresses the growth of human osteosarcoma cells by regulating multiple signaling pathways.
Topics: Antineoplastic Agents, Phytogenic; Benzylisoquinolines; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Humans; Osteosarcoma; Signal Transduction | 2021 |
Tetrandrine inhibits the proliferation of human osteosarcoma cells by upregulating the PTEN pathway.
Topics: Animals; Antineoplastic Agents, Phytogenic; Benzylisoquinolines; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Gene Expression Regulation, Neoplastic; Humans; Mice; Osteosarcoma; PTEN Phosphohydrolase; Signal Transduction; Up-Regulation; Xenograft Model Antitumor Assays | 2017 |
Targeting ABCB1 and ABCC1 with their Specific Inhibitor CBT-1® can Overcome Drug Resistance in Osteosarcoma.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; Benzylisoquinolines; Blotting, Western; Bone Neoplasms; Cell Proliferation; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Fluorescent Antibody Technique; Humans; Microscopy, Fluorescence; Multidrug Resistance-Associated Proteins; Osteosarcoma; Tumor Cells, Cultured | 2016 |
Tetrandrine prevents multidrug resistance in the osteosarcoma cell line, U-2OS, by preventing Pgp overexpression through the inhibition of NF-κB signaling.
Topics: ATP Binding Cassette Transporter, Subfamily B; Benzylisoquinolines; Bone Neoplasms; Cell Line, Tumor; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Neoplasm Proteins; NF-kappa B; Osteosarcoma; Paclitaxel; Signal Transduction | 2017 |